.. | ||
lns.molgen.TA | ||
lns.molgen.TB | ||
lns.T.additional_recommended_evaluations | ||
lns.T.additional_recommended_evaluations_1 | ||
lns.T.additional_recommended_surveillanc | ||
lns.T.additional_recommended_surveillanc_1 | ||
lns.T.additional_treatments_for_individu | ||
lns.T.additional_treatments_for_individu_1 | ||
lns.T.hprt1_disorders_clinical_findings | ||
lns.T.molecular_genetic_testing_used_for | ||
lns.T.notable_hprt1_pathogenic_variants | ||
lns.T.recommended_evaluations_following | ||
lns.T.recommended_surveillance_for_indiv | ||
lns.T.treatment_of_manifestations_in_ind | ||
lns.Tc |